Skip to main content
Figure 3 | Cancer Cell International

Figure 3

From: Enhanced vesicular stomatitis virus (VSVΔ51) targeting of head and neck cancer in combination with radiation therapy or ZD6126 vascular disrupting agent

Figure 3

Representative examples of VSVΔ51 tumour microdistribution in FaDu xenograft tumours. Viral distribution (GFP) was assessed at 24 h post infection in relation to active vasculature (Hoechst, red). The merged field consisted of superimposed VSV, and Hoechst; the close-up images are high-resolution representations of GFP distribution in relation to local blood vessels.

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us